A Changing of the Guard for UR CTSI Translational Biomedical Sciences PhD Program
Timothy D. Dye, Ph.D. is stepping down as the director of the UR CTSI’s Translational Biomedical Science PhD program after five very successful years. He will be succeeded by Edwin van Wijngaarden, Ph.D., a highly experienced educator and mentor, starting July 1.
Case Study: A Single Drug for Multiple Allergies
It can be difficult to treat people with multiple allergic conditions, because drugs are usually tested against a single disease at a time. A recent case study highlights how the drug dupilumab drastically improved symptoms of multiple allergic diseases and quality of life for a young boy.
Spike Patterns May Help Identify Networks Generating Epileptic Seizures
Patients with epilepsy can spend days or weeks undergoing highly invasive pre-surgical evaluation. But a UR CTSI Academic Research Track trainee hopes his recent research findings could someday lead to a better and shorter evaluation for these patients.
UR CTSI-Supported Study Aims to Predict, Prevent Acute Kidney Injury
Acute kidney injury is often preventable, but we currently lack the ability to accurately predict when it will occur and to whom. UR CTSI researchers dug into longitudinal patient data to identify risk factors that can be used to predict and prevent this deadly and debilitating disease.
UR CTSI’s Academic Research Track: Turning Medical Students into Medical Researchers
Ian De Andrea-Lazarus and Samuel Weisenthal joined the University of Rochester's MD-PhD program after participating in the UR CTSI's Academic Research Track (ART). The pair describe ART as the bridge that allowed them to pursue careers as physician-scientists, numbers of which have been declining in recent decades.